We are live on ! Find out more
AP

Atwood & Palmer Portfolio holdings

AUM $1.87B
1-Year Est. Return 24.22%
This Fund
S&P 500
This Quarter Est. Return
+10.59%
1 Year Est. Return
+24.22%
3 Year Est. Return
+82.33%
5 Year Est. Return
+97.89%
10 Year Est. Return
+352.71%
AUM
$1.11B
AUM Growth
+$97.6M
Cap. Flow
+$9.84M
Cap. Flow %
0.89%
Top 10 Hldgs %
29.59%
Holding
402
New
21
Increased
58
Reduced
36
Closed
12
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRE
401
DELISTED
Duke Realty Corp.
DRE
-468
Closed -$23K
BSCM
402
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
-14,075
Closed -$298K

Similar funds

Atwood & Palmer's Q4 2022 Portfolio in Review

As of Q4 2022, Atwood & Palmer held 402 positions worth $1.11B, up 9.7% from $1.01B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Atwood & Palmer's Q4 2022 filing shows 21 new, 58 increased, 36 reduced and 12 closed positions. Its largest new stake was Avantis International Equity ETF: 461,975 shares worth $24.6M. The largest sale was Goldman Sachs ActiveBeta International Equity ETF, an estimated $22.9M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

  • Atwood & Palmer's largest Q4 2022 buy was Avantis International Equity ETF: 461,975 shares worth $24.6M.
  • Atwood & Palmer added most to Janus Henderson AAA CLO ETF in Q4 2022, an estimated $1.69M increase.
  • Atwood & Palmer's biggest Q4 2022 reduction was Goldman Sachs ActiveBeta International Equity ETF, cutting an estimated $22.9M.
  • Atwood & Palmer fully exited Invesco BulletShares 2022 High Yield Corporate Bond ETF in Q4 2022, selling an estimated $532K.
  • Atwood & Palmer's ten largest holdings make up 30% of its $1.11B portfolio in Q4 2022.
  • Atwood & Palmer opened 21 new positions and closed 12 in Q4 2022.
  • Atwood & Palmer's portfolio value rose 9.7% quarter-over-quarter to $1.11B.

Based on Atwood & Palmer's 13F filing for Q4 2022, filed 31 Jan 2023.